Primary dyslipidemia and cardiometabolic risk: potential of pitavastatin.

Primary dyslipidemia and cardiometabolic risk: potential of pitavastatin.

. The review is de­voted to the most important aspects of primary mixed dyslipidemia treatment in patients at high risk with concomitant metabolic comorbidities. Evidences for novel modern approaches regarding primary prevention of cardiovascular events among dyslipidemic patients are considered. Th...

Full description

Bibliographic Details
Main Authors: A. E. Berezin, T. V. Sheychenko, T. A. Berezina, N. V. Vishnevaya, N. V. Kovalenko, Z. I. Kulik, I. А. Мoiseenko
Format: Article
Language:English
Published: SE "Dnipropetrovsk medical academy of Health Ministry of Ukraine" 2015-06-01
Series:Medičnì Perspektivi
Subjects:
dyslipidemia
cardiometabolic risk
statins
pitavastatin
Online Access:http://journals.uran.ua/index.php/2307-0404/article/view/45652

Internet

http://journals.uran.ua/index.php/2307-0404/article/view/45652

Similar Items